Cilium is a networking, observability, and security solution with an eBPF-based dataplane. Prior to versions 1.11.15, 1.12.8, and 1.13.1, under specific conditions, Cilium may misattribute the source IP address of traffic to a cluster, identifying external traffic as coming from the host on which Cilium is running. As a consequence, network policies for that cluster might be bypassed, depending on the specific network policies enabled. This issue only manifests when Cilium is routing IPv6 traffic and NodePorts are used to route traffic to pods. IPv6 and endpoint routes are both disabled by default. The problem has been fixed and is available on versions 1.11.15, 1.12.8, and 1.13.1. As a workaround, disable IPv6 routing.
Published 2023-03-17 20:15:14
Updated 2023-03-24 16:33:46
Source GitHub, Inc.
View at NVD,   CVE.org
Vulnerability category: BypassGain privilege

Exploit prediction scoring system (EPSS) score for CVE-2023-27594

Probability of exploitation activity in the next 30 days: 0.11%

Percentile, the proportion of vulnerabilities that are scored at or less: ~ 44 % EPSS Score History EPSS FAQ

CVSS scores for CVE-2023-27594

Base Score Base Severity CVSS Vector Exploitability Score Impact Score Score Source
7.3
HIGH CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
3.9
3.4
NIST
4.2
MEDIUM CVSS:3.1/AV:A/AC:H/PR:N/UI:N/S:U/C:L/I:L/A:N
1.6
2.5
GitHub, Inc.

CWE ids for CVE-2023-27594

  • The product does not perform or incorrectly performs an authorization check when an actor attempts to access a resource or perform an action.
    Assigned by: security-advisories@github.com (Secondary)
  • The product performs an authorization check when an actor attempts to access a resource or perform an action, but it does not correctly perform the check. This allows attackers to bypass intended access restrictions.
    Assigned by: nvd@nist.gov (Primary)

References for CVE-2023-27594

Products affected by CVE-2023-27594

This web site uses cookies for managing your session, storing preferences, website analytics and additional purposes described in our privacy policy.
By using this web site you are agreeing to CVEdetails.com terms of use!